SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001144204-13-062337
Filing Date
2013-11-15
Accepted
2013-11-15 13:47:02
Documents
1
Group Members
FORESITE CAPITAL IV-B MANAGEMENT, LLCFORESITE CAPITAL IV-B, LLCFORESITE CAPITAL IV-C MANAGEMENT, LLCFORESITE CAPITAL IV-C, LLCFORESITE CAPITAL MANAGEMENT I, LLCJAMES TANANBAUM

Document Format Files

Seq Description Document Type Size
1 SC 13G v360478_sc13g.htm SC 13G 115605
  Complete submission text file 0001144204-13-062337.txt   117322
Mailing Address 2 MERCER ROAD NATICK MA 01760
Business Address 2 MERCER ROAD NATICK MA 01760 508-975-4820
Karyopharm Therapeutics Inc. (Subject) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87705 | Film No.: 131223399
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3052 PACIFIC AVENUE SAN FRANCISCO CA 94115
Business Address ONE MONTGOMERY STREET, SUITE 2500 SAN FRANCISCO CA 94104 415-877-4887
Foresite Capital Fund I, L.P. (Filed by) CIK: 0001562157 (see all company filings)

IRS No.: 900879324 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G